Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Light-based arrhythmia treatment skips the shocks
Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for arrhythmia, according to a press release from the Baltimore school.
The work was published online yesterday in the Journal of Clinical Investigations and could 1 day be used to develop implantable defibrillators, the team suggested. Read more
4. Titan Medical sets $8m to $12m range on overnight offering for Sport surgical bot
Titan Medical said yesterday that it hopes to raise between $8 million and $12 million via an overnight offering it plans to use to restart the development program for its Sport robot-assisted surgery platform.
Toronto-based Titan Medical said the offering, priced at 46.1¢ (C60¢) per unit, will involve between nearly 17.1 million and 26.8 million units. Each unit consists of a share of stock and a 5-year warrant to buy another share at 57.6¢ (C75¢). The gross proceeds would be between C$10.3 million and C$16.1 million, or $7.9 million and $12.3 million. Read more
3. Japan approves Medtronic’s Reveal Linq cardiac monitor
Medtronic wasted no time in launching its Reveal Linq cardiac monitor in Japan, saying it plans to launch the device there this month now that the device won approval from the Ministry of Health, Labor & Welfare.
The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of the chest for monitoring patients experiencing dizziness, palpitation, fainting or syncope, chest pain and cardiac arrhythmias. Billed as the world’s smallest cardiac monitor, it’s about ⅓ the size of a triple-A battery and is designed to work for 3 years using the company’s CareLink network. Its approval in Japan covers its use for monitoring unexplained syncope and cryptogenic stroke, the company said. Read more
2. Stryker to acquire Instratek assets
Stryker said today that it agreed to acquire Instratek for an undisclosed amount at the end of the 4th quarter.
The medtech giant will take on the Houston -based company’s portfolio of staple and hammertoe implants, as well as its minimally invasive soft tissue recession instrumentation. Read more
1. Plaintiff’s loss overturned in Boston Scientific pelvic mesh lawsuit
The plaintiff in the 1st pelvic mesh lawsuit to go to trial against Boston Scientific won a new trial yesterday when a Massachusetts appeals court overturned a 2014 verdict dismissing the case.
Diane Albright alleged that the Pinnacle mesh implanted to treat her pelvic organ prolapse was improperly designed and caused her injuries after it was implanted in 2010. In July 2014, a jury in the Middlesex County Superior Court in Woburn, Mass., found that the device was properly designed and that the medical device company gave adequate warning about risks. Read more
The post MassDevice.com +5 | The top 5 medtech stories for September 14, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2cJHBUW
Cap comentari:
Publica un comentari a l'entrada